Viewing metastatic colorectal cancer as a curable chronic disease

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 1, 2012, Pages 77-80

  Chua, Terence C ^a   Liauw, Winston ^b   Chu, Francis ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

chemotherapy; cytoreductive surgery; liver resection; metastatic colorectal cancer; pulmonary metastasectomy

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; K RAS PROTEIN; OXALIPLATIN;

ANTIANGIOGENIC THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; COLORECTAL SURGERY; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LUNG RESECTION; METASTASIS RESECTION; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PERITONEUM METASTASIS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATTITUDE OF HEALTH PERSONNEL; CAMPTOTHECIN; CHRONIC DISEASE; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; METASTASECTOMY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PATIENT SELECTION; RECURRENCE; REOPERATION; SURVIVAL RATE;

EID: 84856290127     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181fe4444     Document Type: Article

References (27)

1. AIHW, AACR. Cancer in Australia: an Overview, 2008. Cancer Series no 46. Canberra: AIHW; 2008.
2. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma carcinoma sequence in large bowel. Lancet. 1978;1:245-247. (Pubitemid 8268162)
3. Morris M, Lacopetta B, Platell C. Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals. Med J Austral. 2007;186:296-300. (Pubitemid 46534234)
4. AIHW. Cancer Survival and Prevalence in Australia: Cancers Diagnosed From 1982 to 2004. Canberra: AIHW; 2008.
5. Cassidy J, Clarke S, Diaz-Rubio E, et al. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer. J Clin Oncol. 2008;26: 2006-2012.
6. De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol. 1997;15:808-815. (Pubitemid 27074252)
7. De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18: 2938-2947. (Pubitemid 30644117)
8. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 2000;343:905-914.
9. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342. (Pubitemid 38702844)
10. Saltz LB, Clarke S, Diaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a Randomized Phase III Study. J Clin Oncol. 2008;26:2013-2019.
11. Tol J, Koopman M, Cats A, et al. Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer. N Engl J Med. 2009;360:563-572.
12. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer. N Engl J Med. 2008;359:1757-1765.
13. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC Trial. J Clin Oncol. 2009;27:3109-3116.
14. Allegra CJ, Yothers G, O'Connell MJ, et al. Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without Bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer. J Clin Oncol. 2009;27:3385-3390.
15. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984;199:502-508.
16. Spratt JS, Spratt TL. Rates of growth of pulmonary metastases and host survival. Ann Surg. 1964;159:161-171.
17. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358-363. (Pubitemid 30051820)
18. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230: 309-318; discussion 318-321.
19. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007-1016. (Pubitemid 351392040)
20. Niu R, Yan TD, Zhu JC, et al. Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma. Ann Surg Oncol. 2007;14:2078-2087. (Pubitemid 46988268)
21. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-Year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575-4580. (Pubitemid 350035315)
22. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84: 324-338. (Pubitemid 46921128)
23. Chua TC, Thornbury K, Saxena A, et al. Radiofrequency Ablation as an Adjunct to Systemic Chemotherapy for Colorectal Pulmonary Metastases. Cancer. 2010.
24. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743. (Pubitemid 46606227)
25. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681-685.
26. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379-3384.
27. Watkins DJ, Chau I, Cunningham D, et al. Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. Br J Cancer. 2010;102:255-261.